| dc.contributor.author | Tanır Basaranoglu, Sevgen | |
| dc.contributor.author | Ozsurekci, Yasemin | |
| dc.contributor.author | Aykac, Kubra | |
| dc.contributor.author | Arıkan, Kamile Oktay | |
| dc.contributor.author | Buyukcam, Ayse | |
| dc.contributor.author | Cengiz, Ali Bulent | |
| dc.contributor.author | Ceyhan, Mehmet | |
| dc.contributor.author | Kara, Ates | |
| dc.date.accessioned | 2019-12-13T10:58:08Z | |
| dc.date.available | 2019-12-13T10:58:08Z | |
| dc.date.issued | 2017 | |
| dc.identifier.issn | 2090-6625 | |
| dc.identifier.uri | https://doi.org/10.1155/2017/8096420 | |
| dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549487/ | |
| dc.identifier.uri | http://hdl.handle.net/11655/18954 | |
| dc.description.abstract | Optimal therapy for infections with carbapenem resistant GNB is not well established due to the weakness of data. Patients presenting with bloodstream infections caused by multidrug resistant Klebsiella pneumoniae were treated with a combination treatment. Optimal therapy for infections with carbapenem resistant Gram-negative bacteria is a serious problem in pediatric patients. We presented three cases who were successfully treated with addition of ertapenem to the combination treatment for bacteremia with multidrug resistant Klebsiella pneumoniae. Dual carbapenem treatment approach is a new approach for these infections and requires more data in children. | |
| dc.relation.isversionof | 10.1155/2017/8096420 | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.title | Add-On Therapy With Ertapenem In Infections With Multidrug Resistant Gram-Negative Bacteria: Pediatric Experience | |
| dc.type | info:eu-repo/semantics/article | |
| dc.relation.journal | Case Reports in Infectious Diseases | |
| dc.contributor.department | Jeoloji Mühendisliği | |
| dc.identifier.volume | 2017 | |
| dc.description.index | PubMed | |
